Mutations in OAS1 or OAS2 result in impaired functioning of these proteins, and have been found in a small number of pediatric patients who have progressed to multi-inflammatory syndrome (MIS-C) after initially having COVID-1942. This evidence concerns the gene OAS1 and COVID-19–associated multisystem inflammatory syndrome in children.